European Journal of Medicinal Chemistry p. 1 - 13 (2016)
Update date:2022-08-05
Topics:
Qin, Mingze
Yan, Shuang
Wang, Lei
Zhang, Haotian
Zhao, Yanfang
Wu, Shasha
Wu, Di
Gong, Ping
Herein, we report a novel series of diaryl urea derivatives bearing a triazole moiety, from which potent antitumor agents have been identified. With a modified triazole, most compounds showed high level activity in both cellular and enzymatic assays, accompanied with a suitable ClogD7.4 value. The most active compound, 13i, effectively suppressed proliferation of HT-29, H460 and MDA-MB-231 cancer cells, with IC50 values of 0.90, 0.85 and 1.54 μM, respectively. Compound 13i also exhibited significant inhibition of tyrosine kinases including c-Kit, RET and FLT3. Furthermore, compound 13i could obviously induce apoptosis of HT-29 cells in a concentration-dependent manner. The study of structure-activity relationships also revealed that a hydrophilic tail at the 4-position of the triazole was crucial for high activity of the compound.
View MoreWEIFANG RICHEM INTERNATIONAL LTD
Contact:86-536-2222176
Address:weifang,shandong
Wuhan Hanye Chemical New Material Co.,Ltd
Contact:+86-27-85308141
Address:LiuDian, Panlongcheng Economic Development Zone, HuangPi district, Wuhan, Hubei 430311 P.R.China
Chengdu Pukang Biotechnology Co., Ltd
website:http://www.pu-kang.com
Contact:86-028-63976226
Address:No. 868 Xiwang Road,Xinjin county,Chengdu city, China
Taimai Sanluck Pharmaceutical Co.,Ltd
Contact:86-592-7662921
Address:8D,No.186,Huarong Road,Huli,Xiamen,China
Contact:+86-535-8888888
Address:No.161 Haishi Rd.
Doi:10.1039/c39830000132
(1983)Doi:10.1016/j.bmcl.2007.01.094
(2007)Doi:10.1021/jo00166a028
(1983)Doi:10.1021/jo050960+
(2005)Doi:10.1016/j.bmcl.2005.06.005
(2005)Doi:10.1016/j.tet.2005.07.025
(2005)